GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » H U Group Holdings Inc (TSE:4544) » Definitions » Debt-to-Equity

H U Group Holdings (TSE:4544) Debt-to-Equity : 0.49 (As of Dec. 2023)


View and export this data going back to 1983. Start your Free Trial

What is H U Group Holdings Debt-to-Equity?

H U Group Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円10,000 Mil. H U Group Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円60,100 Mil. H U Group Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was 円143,169 Mil. H U Group Holdings's debt to equity for the quarter that ended in Dec. 2023 was 0.49.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for H U Group Holdings's Debt-to-Equity or its related term are showing as below:

TSE:4544' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04   Med: 0.38   Max: 0.75
Current: 0.49

During the past 13 years, the highest Debt-to-Equity Ratio of H U Group Holdings was 0.75. The lowest was 0.04. And the median was 0.38.

TSE:4544's Debt-to-Equity is ranked worse than
65.82% of 196 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs TSE:4544: 0.49

H U Group Holdings Debt-to-Equity Historical Data

The historical data trend for H U Group Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H U Group Holdings Debt-to-Equity Chart

H U Group Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.69 0.70 0.52 0.51

H U Group Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.51 0.44 0.43 0.49

Competitive Comparison of H U Group Holdings's Debt-to-Equity

For the Diagnostics & Research subindustry, H U Group Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H U Group Holdings's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where H U Group Holdings's Debt-to-Equity falls into.



H U Group Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

H U Group Holdings's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

H U Group Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


H U Group Holdings  (TSE:4544) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


H U Group Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of H U Group Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


H U Group Holdings (TSE:4544) Business Description

Traded in Other Exchanges
Address
Shinjuku Mitsui Building, 2-1-1 Nishishinjuku, Shinjuku-ku, Tokyo, JPN, 163-0408
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.

H U Group Holdings (TSE:4544) Headlines

No Headlines